Abstract
Germline loss-of-function variation in TNFAIP3, encoding A20, has been implicated in a wide variety of autoinflammatory and autoimmune conditions, with acquired somatic missense mutations linked to cancer progression. Furthermore, human sequence data reveals that the A20 locus contains ~ 400 non-synonymous coding variants, which are largely uncharacterised. The growing number of A20 coding variants with unknown function, but potential clinical impact, poses a challenge to traditional mouse-based approaches. Here we report the development of a novel functional genomics approach that utilizes a new A20-deficient zebrafish (Danio rerio) model to investigate the impact of TNFAIP3 genetic variants in vivo. A20-deficient zebrafish are hyper-responsive to microbial immune activation and exhibit spontaneous early lethality. Ectopic addition of human A20 rescued A20-null zebrafish from lethality, while missense mutations at two conserved A20 residues, S381A and C243Y, reversed this protective effect. Ser381 represents a phosphorylation site important for enhancing A20 activity that is abrogated by its mutation to alanine, or by a causal C243Y mutation that triggers human autoimmune disease. These data reveal an evolutionarily conserved role for TNFAIP3 in limiting inflammation in the vertebrate linage and show how this function is controlled by phosphorylation. They also demonstrate how a zebrafish functional genomics pipeline can be utilized to investigate the in vivo significance of medically relevant human TNFAIP3 gene variants.
Similar content being viewed by others
Introduction
In mammals, the cytoplasmic ubiquitin-editing enzyme A20, encoded by the TNFAIP3 gene, plays a key role in maintaining inflammatory homeostasis1 mediated by its function to inhibit NF-κB activation2,3,4,5,6. The medical importance of A20’s role in dampening NF-κB is highlighted by cases of germline A20 loss-of-function mutations in humans who present with severe autoinflammatory disease7,8, and by the impact of A20 deletion in mice, which results in spontaneous and widespread NF-κB activation, multi-organ inflammation and premature lethality1,9. The emergence of A20 mutations and coding variants as causal genetic factors driving human disease10,11 highlight the need to understand the functional domains of A20 that control inflammation in vivo.
A20 suppresses NF-κB signalling with inhibitory activity against key signalling molecular substrates, including TNF receptor-associated factor 6 (TRAF6)9, receptor interacting protein 1 (RIP1)12,13, and the IκB kinase complex (IKK)14. The A20 ovarian-tumour (OTU) domain exhibits deubiquitinating editing (DUB) activity centred on Cys103, which cleaves activating K63-linked ubiquitin chains from RIPK1, TRAF6 and NEMO to terminate NF-κB signalling9,12,13,15. The A20 zinc finger 4 (ZnF4) exhibits E3 ligase activity, adding K48-linked ubiquitin chains to RIPK1, triggering RIPK1 proteolysis12,16. In addition, the C-terminal ZnF7 domain of A20 binds linear ubiquitin to non-catalytically suppress NF-κB activity17. A20 is regulated at the level of gene transcription6, whereby NF-κB activation induces TNFAIP3 expression18,19 forming a negative feedback loop, and the inhibitory activities of A20 enzymatic sites are enhanced by IKKB-mediated serine phosphorylation at Ser38120,21.
We have previously shown that coding variants that impair A20 Ser381 phosphorylation13, and thereby reduce the activity of both enzymatic Cys103 and ZnF4 domains of A2012,13,20, exhibited a much larger in vivo effect in mice than mutations that disable the individual enzymatic sites Cys103 and ZnF413,21,22. These data point towards an important role for non-catalytic Ser381 in regulating A20’s anti-inflammatory activity in vivo, however, the in vivo impact of deleting Ser381 has not been tested.
The importance of A20 in human disease, as well as the emerging functional complexities highlighted by experimental studies examining A20 mutations13, coupled with the discovery of new TNFAIP3 coding variants from human genome sequencing studies (e.g. gnomAD) demonstrate the need for novel approaches to investigate A20 functional domains. We hypothesized that elucidation of A20’s conserved regions across additional species may aid the resolution of protein domains of relevance to human disease. Here we report the development of a novel functional genomics pipeline that utilizes the new A20-deficient zebrafish (Danio rerio) model to investigate the impact of TNFAIP3 genetic variants in vivo. We show that A20 is essential for the maintenance of immune homeostasis and survival in zebrafish, demonstrating functionally that the emergence of A20 was essential for regulation of microbial sensing at an early junction in vertebrate evolution. Further, using this zebrafish paradigm we demonstrate how a zebrafish functional genomics approach can be utilized to investigate the in vivo significance of human TNFAIP3 gene variants. These latter studies reveal how phosphorylation regulates A20’s evolutionary conserved anti-inflammatory activity in vivo.
Results
Genomic analysis of the zebrafish tnfaip3 locus
Many of the mammalian components of the NF-κB signalling system23,24 and innate immunity25,26 are conserved in zebrafish making this animal model a candidate in vivo paradigm for the analysis of A20’s key functional regions. This concept was further supported by analysis of zebrafish genomic data which revealed gene order preservation of the TNFAIP3 locus with OLIG3 and PERP in zebrafish (Supplementary Fig. S1A), and a conserved and easily identifiable Topologically Associating Domain (TADs) overlapping with A20 and highly enriched in the regulatory histone mark H3K27ac (histone 3, lysine 27 acetylation) (Supplementary Fig. S1B), a hallmark of active promoters and enhancers27,28. Furthermore, some of these conserved H3K27c marked regions overlapped with the positions of A20 SNPs identified in human genome wide association studies (GWAS) to be linked with Crohn’s disease and Systemic lupus erythematosus (Supplementary Fig. S1A). The tnfaip3 zebrafish orthologue26 encoded a predicted 762 amino acid polypeptide comprising an N-terminal ovarian tumour (OTU) domain (identity score of 94/100), including the putative catalytic cysteine at position 103 in A20’s OTU domain29, and seven zinc finger regions in the C-terminus (identity scores of 79/100) (Supplementary Fig. S2). The zebrafish A20 C-terminal domain also contained zinc finger 4 (ZnF4) and ZnF7 regions, which showed multiple sequence alignment scores of 91/100 and 100/100, respectively, and are thus highly homologous to functional ZnF4 and ZnF7 domains identified in mammalian studies17,21. In mammalian cells A20 expression is controlled at the level of transcription by the NF-κB pathway in response to microbial stimulation of TLR19, a pathway that represents a key component of innate immunity conserved in zebrafish30. Stimulation of cultured zebrafish embryos 3 days post-fertilization (dpf) with 75 µg/ml of the gram-negative bacteria product lipopolysaccharide (LPS) also resulted in the rapid induction of zebrafish (zf) zfA20 (tnfaip3) mRNA as well as TNF (tnf), zfIL-1beta (il1b) and zfIL-6 (il6) mRNA (Fig. 1A).
Generation of a zebrafish model of A20 deficiency
Because A20 deletion in zebrafish had not been previously reported, we utilized site directed transcription activator-like effector nucleases (TALEN) to introduce a disabling mutation within exon 2 of the zebrafish A20 locus (Fig. 1B). A zebrafish line was identified that showed a 20 bp deletion in the tnfaip3 sequence which was predicted to introduce a premature truncation at amino acid 127 (tnfaip3gi3, hereafter A20∆127). Heterozygous A20∆127 zebrafish were bred to homozygosity and deletion of A20 was confirmed in offspring by high-resolution melting assay (HRMA), Sanger sequencing, and analysis of PCR products that differentiate A20 wild-type alleles from A20+/∆127, and A20∆127/∆127 (Supplementary Fig. S3A–C). Heterozygous A20∆127 zebrafish were mated to generate A20+/+, A20+/∆127, and A20∆127/∆127 zebrafish.
A20 deficiency is lethal in zebrafish
To validate the use of A20 deficient zebrafish for testing human A20 variants, we investigated the impact of zebrafish A20 deletion with respect to sentinel A20 phenotypes reported in mammals. The key mouse phenotype is premature lethality1 but also reported in the literature are loss of organ homeostasis, gross anatomical changes (i.e. runting), as well as hyper-responsiveness to TLR-induced NF-κB activity and heightened macrophage activity9,31. Accordingly, A20+/+, A20+/∆127, and A20∆127/∆127 zebrafish were followed through time to assess survival. A20∆127/∆127 zebrafish presented in the expected Mendelian ratios at 1 week post-fertilization (wpf), however, by 2wpf zebrafish homozygous for A20 deletion presented with premature lethality and no A20∆127/∆127 zebrafish survived to three weeks post-fertilization (Fig. 1C). Many A20∆127/∆127 zebrafish also exhibited gross abnormalities including reduced body size (Fig. 1D) and evident malformations of the torso (Fig. 1E). Similar to mice heterozygous for A20 deletion1, A20+/∆127 zebrafish were viable and showed no gross phenotype or lethality (Fig. 1C). Mice lacking A20 present with a rapid and early onset of systemic inflammation of the organs particularly the liver1. To examine the impact of A20 deletion upon organ homeostasis A20 deficient zebrafish were crossed with 2-Color Liver Insulin acinar Pancreas (2CLIP) zebrafish, which express dsRed fluorescent protein driven by the fatty acid binding protein 10 (fabp10) promoter in hepatocytes32. A20∆127/∆127:2CLIP zebrafish are phenotypically runted but also show a marked reduction in liver area to their body size when compared to WT zebrafish (Fig. 1F). Reduction in liver size was not due to a developmental defect as liver size was normal in 1 wpf A20∆127/∆127:2CLIP zebrafish. Confocal analysis of 2wpf A20∆127/∆127:2CLIP zebrafish livers (Fig. 1G), as well as 3-D rendering of the liver (Supplementary Videos S1 and S2), revealed a reduction in liver cellularity, and an increase in caspase-3 positive hepatocytes. We interpret these data to show that A20-deletion resulted in hepatocyte cell death and loss of organ homeostasis.
A20 limits NF-κB activation in zebrafish
Mice deficient for A20 are hyper-responsiveness to TLR-induced NF-κB activation9,31. To investigate NF-κB activation in A20 deficient zebrafish, we generated a transgenic zebrafish reporter line expressing green fluorescent protein (EGFP) under transcriptional control of a NF-κB promoter element (NF-κB:EGFP) and crossed these to A20+/∆127 zebrafish. The spontaneous responsiveness of NF-κB activation in zebrafish in vivo is a direct result of colonization by environmental microbiota24. As shown in Fig. 2A,B, on a wild type background the NF-κB:EGFP reporter demonstrates spontaneous activation. NF-κB driven fluorescence was found to be at its highest expression in those tissues that mostly interact with the external environment, namely the mouth, neuromasts, pharyngeal tooth, gills and gut (Fig. 2A). Also, NF-κB driven fluorescence increased through time (compare 3dpf A20+/+ zebrafish with 6dpf; Fig. 2B,C) most likely reflecting exposure to environmental microbiota24, and this was increased further in A20+/∆127 and A20∆127/∆127 zebrafish in a gene dose manner (Fig. 2D). Furthermore, the addition of LPS to zebrafish embryos further enhanced NF-κB activation and this was most pronounced in A20∆127/∆127 zebrafish (Fig. 2D).
Zebrafish A20-deficient macrophages are hyper-responsive to inflammatory triggers
A20 loss of function mutations result in macrophage hyper responsiveness to microbial stimulation and spontaneous inflammasome activation9,13,17. Tissue macrophages play a key role in sensing pathogenic microbiota in zebrafish. To investigate the impact of A20 deletion on macrophage homeostasis, heterozygous A20+/∆127 zebrafish were crossed to a macrophage reporter line whereby RFP is expressed under the control of the promotor of macrophage-expressed gene 1.1 (mpeg1.1). The number of macrophages detected in the skin was ~ 2- to 4-fold higher in A20∆127/∆127 zebrafish when compared to their wild type counterparts (Fig. 3A,B). We also created a A20∆127/∆127 T cell reporter line whereby RFP is expressed under the control of the lymphocyte-specific protein tyrosine kinase promotor lck, this reporter line showed that A20 deletion also led to increased numbers of dermal T cells (Fig. 3C,D). In addition to increased numbers, the majority of dermal macrophages in A20∆127/∆127 zebrafish exhibited dendritic extensions (Fig. 3A magnification) indicative of an activated state33,34. Imaging of double reporter (NF-κB:EGFP x mpeg1.1:RFP) WT zebrafish by two-photon microscopy (Fig. 3E, Supplementary Video S3) showed co-localisation of NF-κB activation with MPEG1 reporter expression further highlighting activation of dermal macrophages in A20∆127/∆127 zebrafish. This was also made further apparent by histological analysis through transverse sections of the cranium, which revealed dense infiltration of mpeg1.1 positive cells close to the dermal surface (Supplementary Fig. S4). From these cranial sections it could be seen that the position of the mpeg1.1 positive cells corresponded with cells at the dermal surface exhibiting bright NF-κB:EGFP reporter activity.
Recruitment to sites of inflammation constitute important physiological roles for the macrophage immune compartment. Using a tail clip wound model35 we found that both A20+/∆127 and A20∆127/∆127 zebrafish showed an increased recruitment of macrophages at the wound interface through time (Fig. 3F). Interestingly, this analysis revealed a macrophage phenotype for heterozygous A20+/∆127 zebrafish post challenge whereas we did not observe a change in A20+/∆127 macrophage numbers in the steady state (Fig. 3B). To investigate this further, we used two-photon imaging of single mpeg1.1:RFP reporter A20+/∆127 zebrafish to track individual macrophage cell movement in vivo in real time (Fig. 3G,H, supplemented by Supplementary Video S4). This analysis revealed that A20+/∆127 macrophages exhibited increased cell movement in the steady state (track length:displacement ratio = 3.95 for WT macrophages versus 4.55 for A20+/∆127 macrophages), and was attributed to increases in track speed, track displacement and track length (Fig. 3H).
Human A20 rescues A20∆127/∆127 zebrafish from lethality
The phenotypic similarities between A20-deficient zebrafish and those reported for A20-deficient mice1,9,17, as well as the profound inflammatory syndromes reported for human subjects with heterozygous A20 deficiency8, supported utilizing zebrafish as a model organism to investigate the role of A20 protein domains in regulating its function in vivo. For our functional analysis pipeline, we determined that rescue of A20∆127/∆127 zebrafish from lethality would provide the most robust readout for loss or gain of function phenotypes in various A20 genetic variants. For the functional analysis, zebrafish eggs derived from A20+/∆127 × A20+/∆127 crosses were ectopically injected with wild-type human (h)A20 expressed in the construct Ubb-hA20-P2A-EGFP that also expresses GFP. The low integration Ubb-hA20-P2A-EGFP construct was chosen to limit potential off-target effects as well as false positives36,37,38. The zebrafish eggs were injected in a blinded fashion with the Ubb-hA20-P2A-EGFP construct and were assessed for the presence of GFP fluorescence (Supplementary Fig. S5A). Human A20 expression in injected embryos was confirmed by mRNA analysis (Supplementary Fig. S5B). At 1 wpf A20∆127/∆127 zebrafish presented in the expected mendelian ratio of ~ 25% of genotypes (Fig. 1C) but later exhibited a highly penetrant lethal phenotype with no survivors at 3wpf (Fig. 4A). In contrast, with ectopic expression of hA20, A20∆127/∆127 zebrafish now comprised 9.91% of the total of all genotypes at 3wpf (Fig. 4A). Further, all surviving A20∆127/∆127 zebrafish were positive for EGFP expression derived from the Ubb-hA20-P2A-EGFP construct (Supplementary Fig. S5C). Given an expected Mendelian ratio of 25%, ectopic expression of hA20 rescued ~ 40% of A20∆127/∆127 zebrafish from lethality highlighting the strong evolutionary conservation for A20’s function across the veterbrate lineage.
Alanine substitution of Ser381 and the human mutation C243Y impairs A20’s in vivo function
We previously demonstrated that a series of A20 coding variants, all within A20’s OTU domain, showed a strong correlation between a graded loss of A20’s NF-κB inhibitory function and an increasing hyper-inflammatory in vivo phenotype with reduced phosphorylation at Ser38113. The coding variant C243Y which showed the strongest in vivo phenotype and caused the greatest reduction in Ser381 phosphorylation was originally identified in a four generation Japanese family with hereditary autoinflammatory disease7. In vitro biochemical studies show that IκB kinase beta (IKKβ)-dependent phosphorylation at Ser381 is required for A20’s optimal NF-κB and JNK suppressive function13,20,39 (Fig. 4B; Supplementary Fig. S5D,E). Both Ser381 and Cys243 are conserved in zebrafish (Supplementary Fig. S2) allowing us to test the impact of alanine substitution at Ser381, and the impact of the disease causing variant C243Y on the ability of human A20 to rescue A20∆127/∆127 zebrafish from lethality.
As shown in Fig. 4A, ectopic injection of either S381A or C243Y expressing constructs into A20∆127/∆127 embryos rescued less fish from death compared to A20∆127/∆127 embryos that received wild-type hA20-expressing constructs. Specificity for the impact of S381A and C243Y on A20’s in vivo function was shown by ectopic injection of another OTU domain mutant, namely the C103A DUB mutant13,21,22, which niether impaired A20’s ability to rescue A20∆127/∆127 embryos from lethality, nor A20’s ability to block NF-κB or JNK signalling in vitro (Fig. 4A,B; Supplementary Fig. S5D,E). The in vivo rescue properties of individual A20 mutants did not relate to differences in protein stability, as shown by Western blot analysis of A20 protein levels when expressed in cell lines (Fig. 4B)13, nor differences in the levels of transgene expression in vivo as measured by the levels of GFP fluorescence which is co-expressed with A20 in the Ubb-hA20-P2A-EGFP construct (Supplementary Fig. S5A).
Discussion
A20 inhibits NF-κB activation in mammals in response to TLR signals1,9, and uncontrolled NF-κB activation results in excessive inflammation and lethality40, yet there is little information regarding the in vivo functional role of A20 beyond mammalian models. An A20-like protein sequence has been identified in the purple sea urchin and amphioxus41 and in the lamprey genomes42 and here we identify a functional A20 homologue in zebrafish. In contrast, we did not find a homologous A20 sequence in the genomes of lower invertebrates including Drosophila. Similar to mammalian cells, and as shown here for zebrafish, A20 expression in amphioxus is also regulated by LPS19,41 and in both amphioxus and mammalian cells A20 modulates NF-κB signalling via a ubiquitin editing function13,21,41. However, the in vivo functional significance of A20 in amphioxus has not been tested41. Reminiscent of mouse data1,9, we found that A20 deficiency in zebrafish resulted in spontaneous hyper-responsiveness to environmental microbiota with early lethality. Remarkably re-introduction of human A20 could rescue a proportion of A20-deficient zebrafish from lethality. These data highlight the strong functional evolutionary conservation for A20 in vertebrates, suggesting that A20 arose early during chordate evolution to regulate inflammatory homeostasis. As the major components of NF-κB signalling in mammals are conserved to Drosophila13,43 it is unclear as to why A20-dependent control of NF-κB signalling was required for chordate evolution, but further studies to investigate A20 function in the purple sea urchin would be informative. In mammalian cells A20 has been shown to regulate diverse signalling cascades that control inflammation and cell death in both hematopoietic and non-hematopoietic cell lineages10,44. Further investigation of A20’s function in non-mammalian systems like zebrafish will reveal to what extent these critical mammalian functions extend to other vertebrates and aid our understanding of the evolutionary significance of A20.
Gene targeting in mice to either introduce an alanine at Cys103 (C103A) that eliminates biochemical OTU DUB activity21, or a mutation that destroys the ZnF4 E3 ligase activity of A2022, resulted in surprisingly little or no impact on lipopolysaccharide (LPS) responses and inflammatory homeostasis in vivo22,45, contrasting the lethal hyper-inflammatory phenotype of A20-deficient mice1,9. These findings indicate compensatory activity of the Cys103 and ZnF4 catalytic domains towards each other, and redundancy in the mechanism by which the OTU domain regulates NF-κB activation, which may include both catalytic and non-catalytic roles12,14. Previous biochemical studies have shown that A20’s NF-κB inhibitory activity requires phosphorylation at Ser381 by IκB-kinase20,21. We previously provided evidence for the importance of Ser381 in vivo13. We demonstrated how a series of A20 coding variants that cause a decrease in phosphorylation at Ser381 also decrease A20’s NF-κB inhibitory activity in a graded manner, with a corresponding reduction in the ability of A20 to control inflammatory homeostasis in vivo. Such coding variants can have medical relevance, they may be beneficial by increasing protective immunity to pathogens13, however increased tissue inflammation may also be detrimental in situations including autoimmune disease7 and organ transplantation46.
Here, using a new zebrafish functional genomics approach, we show evidence that Ser381 phosphorylation is needed for A20’s optimal anti-inflammatory function in vivo by directly targeting Ser381. Targeted mutation of Ser381 impaired the ability of A20 to rescue A20∆127/∆127 zebrafish from lethality. Reduced Ser381 phosphorylation disables both the OTU DUB and ZnF4 ubiquitin editing functions of A2013. This could explain the highly penetrant phenotype seen for both zebrafish and mice13 carrying variants that impact Ser381 when compared to the relatively mild phenotypes observed in mice carrying mutations that disable the individual catalytic domains22,45. Further studies are required to understand how phosphorylation at Ser381 impacts A20’s function but one possibility is that phosphorylation causes changes to A20 structure facilitating interactions between A20’s distinct ubiquitin binding and ubiquitin editing domains with ubiquitin. Indeed, two studies highlight the importance of ubiquitin binding domains (i.e. ZF4 and ZF7) in preventing inflammatory disease47,48. We predict that access to ubiquitin by these domains is regulated by A20 phosphorylation13. Understanding how specific molecular changes in A20 effect function and cellular phenotypes may provide a pathway to understand the seemingly broad association of A20 to many different tissue specific autoimmune diseases identified through GWAS10 and the broad clinical phenotypes emerging in patients identified with A20 haploinsufficiency41,49,50.
A20 deletion results in severe autoinflammatory disease in humans31,49,50,51,52. The severe impact of mutating Ser381 on A20 function shown here, and the discovery of an ever-increasing number of new A20 coding variants through human sequencing studies13, raise the question as to the existence of further human coding variants, which may present with highly penetrant phenotypes and contribute to disease. The conservation of A20 in zebrafish allows us to construct a functional genomics pipeline to investigate the impact of medically and scientifically important human A20 coding variants in vivo. The discovery of the cysteine to tyrosine substitution at position 243 (C243Y) in a four generation Japanese family with a Behcet’s like disease7, together with the high level of sequence homology across the mammalian and zebrafish OTU domains which included this residue, provided an opportunity to test the sensitivity of the zebrafish pipeline. In this zebrafish model the C243Y mutation caused a reduction in A20’s ability to rescue homozygous A20-null zebrafish from lethality. This in vivo proof of concept data in the zebrafish model showing that C243Y is a reduction of function variant is supported by the human genetic data7, as well as biochemical and mouse data13. A20 variants like C243Y that modify phosphorylation at Ser381 therefore represent a novel class of variants with medically relevant disease-causing potential.
We highlight the potential of the zebrafish system to advance our knowledge of medically significant A20 gene variants by taking advantage of regions of high homology. In addition to shedding light on the functional significance of A20 coding variants, the conservation of the zebrafish A20 genomic locus may also aid the elucidation of non-coding variants. GWAS studies associate A20 with multiple autoimmune conditions and many identified SNPs are non-coding10. Analysis of conserved trans regulatory regions in the A20 locus marked by active methylation marks revealed an overlap with two SNPs associated with Crohn’s disease (rs7753394; rs7773904) (GRCh38) and one associated with Systemic lupus erythematosus (rs10499197)53,54,55. As these SNP’s lay in putative enhancer regions, they may alter A20 expression levels thereby contributing to disease. The development of a novel functional genomics pipeline that utilizes A20-deficient zebrafish model provides a new tool to investigate the impact of TNFAIP3 genetic variants in vivo. Understanding the underlying genetic code of A20 will have relevance for understanding human disease mechanisms and the development of targeted drug therapies. This same approach could be utilized to increase understanding of the impact of human genetic variation for other highly conserved genes.
Materials and methods
Zebrafish
Fertilized eggs were collected from zebrafish (Danio rerio) group matings and incubated at 28.5 °C at a density < 60 embryos in ~ 25 mL E3 egg water. Adult zebrafish were maintained under standard conditions at 28.5 °C and pH 7–8 at a density of 5–10 fish L−1 under a photoperiodic cycle of 14/10 light/dark hours. Genotyping was performed by fin clipping and HotSHOT DNA extraction56,57 followed by High Resolution Melting assay. Animal studies were approved by the Garvan/St Vincent's Animal Ethics Committee. All procedures performed complied with the Australian Code of Practice for Care and Use of Animals for Scientific Purposes.
Genomic structure of A20
HiC data (40 Kb resolution) corresponding to H1 cells were visualized in the 3D genome browser58 (hg19 genome assembly). Layered H3K27ac ChIP-seq data from seven cell lines (GM12878, H1-hESC, HSMM, HUVEC, K562, NHEK, NHLF), available through the UCSC genome browser59 were generated by the ENCODE consortium (2012). Zebrafish 24hpf embryo H3K27ac ChIP-seq reads were mapped by Bowtie60 to unique genomic positions, followed by duplicate removal. Mapped ChIP-seq reads were visualized in WIG format as previously described61 utilizing the UCSC genome browser.
Tnfaip3 knockout line
A pair of TALENs targeting zebrafish tnfaip3 (A20) exon 2 were generated using “PLATINUM Gate TALEN Kit” (Addgene, #1000000043). 0.2 ng of mRNA encoding the TALEN pair was delivered into the cytoplasm of wild-type zebrafish embryos at the one-cell stage. Founders were genotyped using the following primers: zfA20_Fw: AGTATCTGCTGGGGGTTCAGGA and zfA20_Rev: CACCGCATGCAGAGCTT. Subsequently a founder line was identified harbouring a 20 bp deletion in exon 2 with a predicted stop codon at amino acid 127. The tnfaip3dGI4 A20-deficient line was maintained in the heterozygous state (tnfaip3∆127/tnfaip3+) and crossed to the zebrafish reporter lines described below.
Zebrafish reporter lines
The lck:RFP (TgBAC(lck:RFP)vcc4) and mpeg1.1:RFP (TgBAC(mpeg1.1:RFP)vcc7) reporter lines have been described previously. The lymphocyte protein tyrosine kinase (lck) promoter targets gene expression to T cells whereas macrophage expressed gene 1.1 (mpeg1.1) promoter targets gene expression to macrophages. The Tg(ins:dsRed)m1081;Tg(fabp10:dsRed;ela3l:GFP)gz12 line, known as 2-Color Liver Insulin acinar Pancreas (2CLIP) fish line, has been described previously62. This fish express dsRed fluorescent protein both in the hepatocytes, driven by the fatty acid binding protein 10 (fabp10 gene), and in the islets of the endocrine pancreas, driven by the insulin promoter (insulin gene). The exocrine pancreas instead expresses GFP driven by the pancreas specific transcriptor factor 1a (ptf1a gene). We generated the NF-κB reporter line Tg(NF-κB, c-FOS:EGFP)GI5 zebrafish line was generated using the Tol2 system to insert a DNA fragment containing six repeats of an NF-κB binding site in tandem with a minimal c-Fos promoter that drive the expression of EGFP, followed by an SV40 polyadenylation signal sequence (SV40pA), this construct has been previously reported24.
Fluorescence quantification through ImageJ
Live zebrafish were placed in a gel solution (1 × E3 solution, 3% methyl cellulose, 5% Tricaine), in a 150 mm petri dish lid. Fish were placed on the left side up. Images were processed using ImageJ (v.1.50b). In the case of the NF-κB:EGFP line fluorescence measurements, an outline of the fish was drawn by hand, excluding the yolk sack due to its auto fluorescence. Measurement values of area (pixel/inch) and integrated density (area × mean grey value) were recorded for each of the measured fish. Background value was subtracted to the fish intensity value.
NF-κB and JNK reporter assays
The NF-κB reporter assay was conducted exactly as described previously19. In brief, human Embryonic Kidney 293T (HEK293T) cells63 were cultured in Dulbecco's Modified Eagle's medium (DMEM) and incubated at 37 °C in 5% CO2 and kept at a passage number between 21–40 for experiments. Cells were transfected using Lipofectamine 2000 (ThermoScientific #11668019) with β-galactosidase (β-gal) and NF-κB.Luc with either ‘empty’ pcDNA3.1 vector (NTC; non template control) or pcDNA3.1 encoding wild-type human-A20 or either the A20 mutant Cys103Ala or Ser38Ala. HEK293T cells were stimulated with 300 U/ml of recombinant human TNFα (RandD Systems, Minneapolis, MN; #210-TA) for 8 h. To assess the effect of A20 mutants on JNK signalling, HEK293T cells which constitutively expresses mCherry Kinase Translocation Reporter (mCherryKTR) which translocates from the nucleus to the cytoplasm when phosphorylated by JNK were used (de la Cova, Townley et al. 2017). JNK activity was determined by measuring the ratio between nucleus and cytoplasmic mCherry in cells transiently transfected with human-A20 mutants (using JetPRIME reagent) following human TNFα stimulation. Each experiment included automated cell imaging (Thermo Scientific Cellomics Arrayscan machine) of ~ 150,000 to ~ 350,000 individual cells per well in duplicate wells over a period of 60 min (5 min intervals).
Generation of A20 mutants for ectopic expression in zebrafish
Three A20 mutants were generated for this study. Mutations were introduced into cDNA encoding full length human A20 by site directed mutagenesis to cause an alanine substitution at position Cys103 (C103A), a second clone at Ser381 (S381A) and a third clone a Tyrosine at position Cys243 (C243Y). Wild type A20 or mutant C103A, S381A or C243Y A20-cDNA were cloned into the expression cassette Ubb-[A20 insert]-P2A-EGFP and ~ 100 ng/μl of DNA was co-injected with I-SceI meganuclease to promote random integration in the zebrafish genome. Glass needles for zebrafish eggs injections were prepared from glass capillary tubes with filament (ø1 mm × 90 mm) (WPI #1B100F-3) using a NARISHIGE dual-stage micropipette puller PC-10 machine. The injections were all performed between the one and two-cell stage of development. The pUbb-hA20-P2A-EGFP was generated by modifying the published plasmid pUbb-iCre-EGFP64 in which iCre is fused to EGFP via a P2A sequence which sits downstream of the promoter of the zebrafish ubb gene. The entire cassette is flanked with with I-SceI (NEB, Ipswich, MA) sites. To generate pUbb-hA20-P2A-EGFP, iCre cDNA of pUbb-iCre-EGFP was replaced with hA20 cDNA using restriction enzyme digest cloning, and the resultant plasmid was co-injected with I-SceI into one-cell-stage embryos.
Two-photon intravital microscopy
Two-photon imaging was performed using an upright Zeiss 7MP two-photon microscope (Carl Zeiss) with a W Plan-Apochromat 20 × /1.0 DIC (UV) Vis-IR water immersion objective. Four external NDDs were used to detect blue (SP 485), green (BP 500–550), red (BP 565–610) and far red (BP 640–710). High repetition rate femtosecond pulsed excitation was provided by a Chameleon Vision II Ti:Sa laser (Coherent Scientific) with 690–1064 nm tuning range. We acquired 3 μm z-steps at 512 × 512 pixels and resolution 0.83 μm/pixel at a frame rate of 10 fps and dwell time of 1.27 μs/pixel using bidirectional scanning. Intravital two-photon microscopy was performed by embedding 1 wpf zebrafish in 1% low melting point agarose in E3 water and 0.4% Tricaine to limit the overall tissue drifting and motility of the fish.
Image processing and data analysis
Raw image files were processed using Imaris (Bitplane) software. A Gaussian filter was applied to reduce background noise. Tracking was performed using Imaris spot detection function to locate the centroid of cells. Motility parameters such as cell displacement (or track length calculated as the total length of displacements within the track) were obtained using Imaris Statistics function.
Statistical analysis
Data were analysed as appropriate using a nonparametric Mann–Whitney test, a Whelch t-test, Area under the curve (AUC) or a one-way ANOVA test. Statistical analyses were carried out using GraphPad Prism v7.0. In all cases, the significance threshold was set at p ≤ 0.05. For clarity, only significant comparisons were reported on each graph.
References
Lee, E. G. Failure to regulate TNF-induced NF-kappa B and cell death responses in A20-deficient mice. Science 289, 2350–2354. https://doi.org/10.1126/science.289.5488.2350 (2000).
Cooper, J. T. et al. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J. Biol. Chem. 271, 18068–18073 (1996).
Grey, S. T., Arvelo, M. B., Hasenkamp, W., Bach, F. H. & Ferran, C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J. Exp. Med. 190, 1135–1146 (1999).
Song, H. Y., Rothe, M. & Goeddel, D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 93, 6721–6725 (1996).
Jaattela, M., Mouritzen, H., Elling, F. & Bastholm, L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156, 1166–1173 (1996).
Dixit, V. M. et al. Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J. Biol. Chem. 265, 2973–2978 (1990).
Shigemura, T. et al. Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behcet’s disease. RMD Open 2, e000223. https://doi.org/10.1136/rmdopen-2015-000223 (2016).
Zhu, L. et al. Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis. J. Transl. Med. 13, 215. https://doi.org/10.1186/s12967-015-0566-1 (2015).
Boone, D. L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052–1060. https://doi.org/10.1038/ni1110 (2004).
Ma, A. & Malynn, B. A. A20: Linking a complex regulator of ubiquitylation to immunity and human disease. Nat. Rev. Immunol. 12, 774–785. https://doi.org/10.1038/nri3313 (2012).
Vereecke, L., Beyaert, R. & van Loo, G. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. Biochem. Soc. Trans. 39, 1086–1091. https://doi.org/10.1042/BST0391086 (2011).
Wertz, I. E. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430, 694–699. https://doi.org/10.1038/nature02794 (2004).
Zammit, N. W. et al. Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity. Nat. Immunol. 20, 1299–1310. https://doi.org/10.1038/s41590-019-0492-0 (2019).
Skaug, B. et al. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol. Cell 44, 559–571. https://doi.org/10.1016/j.molcel.2011.09.015 (2011).
Evans, P. C. et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378, 727–734. https://doi.org/10.1042/bj20031377 (2004).
Shembade, N., Ma, A. & Harhaj, E. W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135–1139. https://doi.org/10.1126/science.1182364 (2010).
Polykratis, A. et al. A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain. Nat. Cell Biol. 21, 731–742. https://doi.org/10.1038/s41556-019-0324-3 (2019).
Krikos, A., Laherty, C. D. & Dixit, V. M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J. Biol. Chem. 267, 17971–17976 (1992).
Liuwantara, D. et al. Nuclear factor-kappaB regulates beta-cell death: A critical role for A20 in beta-cell protection. Diabetes 55, 2491–2501. https://doi.org/10.2337/db06-0142 (2006).
Hutti, J. E. et al. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell. Biol. 27, 7451–7461. https://doi.org/10.1128/mcb.01101-07 (2007).
Wertz, I. E. et al. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528, 370–375. https://doi.org/10.1038/nature16165 (2015).
Lu, T. T. et al. Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity 38, 896–905. https://doi.org/10.1016/j.immuni.2013.03.008 (2013).
Correa, R. G. et al. Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development. Mol. Cell. Biol. 24, 5257–5268. https://doi.org/10.1128/mcb.24.12.5257-5268.2004 (2004).
Kanther, M. et al. Microbial colonization induces dynamic temporal and spatial patterns of NF-κB activation in the zebrafish digestive tract. Gastroenterology 141, 197–207. https://doi.org/10.1053/j.gastro.2011.03.042 (2011).
Novoa, B., Bowman, T. V., Zon, L. & Figueras, A. LPS response and tolerance in the zebrafish (Danio rerio). Fish Shellfish Immunol. 26, 326–331. https://doi.org/10.1016/j.fsi.2008.12.004 (2009).
Oehlers, S. H. et al. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish. Dis. Model. Mech. 4, 832–841. https://doi.org/10.1242/dmm.006122 (2011).
Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U. S. A. 107, 21931–21936. https://doi.org/10.1073/pnas.1016071107 (2010).
Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279–283. https://doi.org/10.1038/nature09692 (2011).
Komander, D. & Barford, D. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem. J. 409, 77–85. https://doi.org/10.1042/BJ20071399 (2008).
Phelan, P. E., Mellon, M. T. & Kim, C. H. Functional characterization of full-length TLR3, IRAK-4, and TRAF6 in zebrafish (Danio rerio). Mol. Immunol. 42, 1057–1071. https://doi.org/10.1016/j.molimm.2004.11.005 (2005).
Matmati, M. et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 43, 908–912. https://doi.org/10.1038/ng.874 (2011).
Her, G. M., Chiang, C. C., Chen, W. Y. & Wu, J. L. In vivo studies of liver-type fatty acid binding protein (L-FABP) gene expression in liver of transgenic zebrafish (Danio rerio). FEBS Lett. 538, 125–133 (2003).
Kigerl, K. A. et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435–13444. https://doi.org/10.1523/jneurosci.3257-09.2009 (2009).
Jablonski, K. A. et al. Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE 10, e0145342. https://doi.org/10.1371/journal.pone.0145342 (2015).
Renshaw, S. A. et al. A transgenic zebrafish model of neutrophilic inflammation. Blood 108, 3976–3978. https://doi.org/10.1182/blood-2006-05-024075 (2006).
Grabher, C. & Wittbrodt, J. Meganuclease and transposon mediated transgenesis in medaka. Genome Biol. 8, 1–7. https://doi.org/10.1186/gb-2007-8-s1-s10 (2007).
Soroldoni, D., Hogan, B. M. & Oates, A. C. In Zebrafish: Methods and Protocols (eds Graham Lieschke, J., Andrew Oates, C., & Kawakami, K.) 117–130 (Humana Press, Totowa, 2009).
Hoshijima, K., Jurynec, M. J. & Grunwald, D. J. Precise editing of the zebrafish genome made simple and efficient. Dev. Cell 36, 654–667. https://doi.org/10.1016/j.devcel.2016.02.015 (2016).
Zhou, Q. et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat. Genet. 48, 67–73. https://doi.org/10.1038/ng.3459 (2016).
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167–170. https://doi.org/10.1038/376167a0 (1995).
Yuan, S. et al. Emergence of the A20/ABIN-mediated inhibition of NF-kappaB signaling via modifying the ubiquitinated proteins in a basal chordate. Proc. Natl. Acad. Sci. U. S. A. 111, 6720–6725. https://doi.org/10.1073/pnas.1321187111 (2014).
Smith, J. J. et al. The sea lamprey germline genome provides insights into programmed genome rearrangement and vertebrate evolution. Nat. Genet. 50, 270–277. https://doi.org/10.1038/s41588-017-0036-1 (2018).
Dushay, M. S., Asling, B. & Hultmark, D. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. U. S. A. 93, 10343–10347. https://doi.org/10.1073/pnas.93.19.10343 (1996).
Catrysse, L., Vereecke, L., Beyaert, R. & van Loo, G. A20 in inflammation and autoimmunity. Trends Immunol. 35, 22–31. https://doi.org/10.1016/j.it.2013.10.005 (2014).
De, A., Dainichi, T., Rathinam, C. V. & Ghosh, S. The deubiquitinase activity of A20 is dispensable for NF-kappaB signaling. EMBO Rep. 15, 775–783. https://doi.org/10.15252/embr.201338305 (2014).
Zammit, N. W. et al. A20 as an immune tolerance factor can determine islet transplant outcomes. JCI Insight 4, e131028. https://doi.org/10.1172/jci.insight.131028 (2019).
Razani, B. et al. Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation. Nat. Immunol. 21, 422–433. https://doi.org/10.1038/s41590-020-0634-4 (2020).
Martens, A. et al. Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities. Nat. Immunol. 21, 381–387. https://doi.org/10.1038/s41590-020-0621-9 (2020).
Chu, Y. et al. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. Blood 117, 2227–2236. https://doi.org/10.1182/blood-2010-09-306019 (2011).
Heger, K. et al. A20-deficient mast cells exacerbate inflammatory responses in vivo. PLoS Biol. 12, e1001762. https://doi.org/10.1371/journal.pbio.1001762 (2014).
Nagamachi, A. et al. Acquired deficiency of A20 results in rapid apoptosis, systemic inflammation, and abnormal hematopoietic stem cell function. PLoS ONE 9, e87425. https://doi.org/10.1371/journal.pone.0087425 (2014).
Nakagawa, M. M., Thummar, K., Mandelbaum, J., Pasqualucci, L. & Rathinam, C. V. Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence. J. Exp. Med. https://doi.org/10.1084/jem.20132544 (2015).
Eleftherohorinou, H. et al. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS ONE 4, e8068. https://doi.org/10.1371/journal.pone.0008068 (2009).
Vereecke, L. et al. A20 controls intestinal homeostasis through cell-specific activities. Nat. Commun. 5, 5103. https://doi.org/10.1038/ncomms6103 (2014).
Graham, R. R. et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40, 1059–1061. https://doi.org/10.1038/ng.200 (2008).
Meeker, N. D., Hutchinson, S. A., Ho, L. & Trede, N. S. Method for isolation of PCR-ready genomic DNA from zebrafish tissues. Biotechniques 43, 610 (2007).
Thomsen, N., Ali, R. G., Ahmed, J. N. & Arkell, R. M. High resolution melt analysis (HRMA); A viable alternative to agarose gel electrophoresis for mouse genotyping. PLoS ONE 7, e45252. https://doi.org/10.1371/journal.pone.0045252 (2012).
Wang, Y. et al. The 3D Genome Browser: A web-based browser for visualizing 3D genome organization and long-range chromatin interactions. Genome Biol. 19, 151. https://doi.org/10.1186/s13059-018-1519-9 (2018).
Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996–1006. https://doi.org/10.1101/gr.229102 (2002).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25. https://doi.org/10.1186/gb-2009-10-3-r25 (2009).
Bogdanovic, O. et al. Dynamics of enhancer chromatin signatures mark the transition from pluripotency to cell specification during embryogenesis. Genome Res. 22, 2043–2053. https://doi.org/10.1101/gr.134833.111 (2012).
Farooq, M. et al. Histone deacetylase 3 (hdac3) is specifically required for liver development in zebrafish. Dev. Biol. 317, 336–353. https://doi.org/10.1016/j.ydbio.2008.02.034 (2008).
Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59–74. https://doi.org/10.1099/0022-1317-36-1-59 (1977).
Sugimoto, K., Hui, S. P., Sheng, D. Z. & Kikuchi, K. Dissection of zebrafish shha function using site-specific targeting with a Cre-dependent genetic switch. eLife https://doi.org/10.7554/eLife.24635 (2017).
Acknowledgements
We thank the Biological Testing Facility at the Garvan Institute of Medical Research for fish care, and David Zahra (Genomic Engineering, Garvan Institute of Medical Research) for helpful advice with design of TALEN constructs, cloning and site directed mutagenesis of A20 mutants. We thank Dr John Rawls (Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill) for the NF-κB:EGFP transgenic construct. D.C. and N.W.Z were each supported by an Australian Postgraduate Award and N.W.Z. is an International Pancreas and Islet Transplant Association (IPITA) Derek Gray Fellow. The research was supported by National Health and Medical Research (NHMRC) grants to S.T.G. (1130222, 1189235) and K.K. (1130247); as well as grants from NIH (DK076169) to D.H. and to S.T.G.; and to S.T.G. from the Australian Juvenile Diabetes Research Foundation (3-SRA-2018-604-M-B). S.T.G. is NHMRC Senior Research Fellow (1140691).
Author information
Authors and Affiliations
Contributions
D.C.; B.P.; D.H.; S.T.G.; generated the Tg(NF-κB, c-FOS:EGFP)GI1. D.C.; S.T.G.; generated the tnfaip3GI2 zebrafish lines. O.B.; analysed A20 locus genomic structure, and HiC and H3K27c CHIP data. D.C.; conducted all in vivo zebrafish studies. D.C.; N.W.Z.; conducted cloning of human A20 and A20 mutants, Western blotting experiments and NF-κB reporter assays. D.C.; J.Z.R.H.; D.C.; conducted JNK reporter assays. J.B.; T.C.; conducted intravital imaging experiments. J.W.; D.C.; E.S.; conducted immunohistochemistry analysis. K.K.; provided essential zebrafish expertise and generated zebrafish T cell and macrophage reporter lines. All authors critically assessed data. D.C.; S.T.G.; co-wrote the manuscript. S.T.G.; devised and led the experimental plan and is guarantor of the study.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Video 1.
Supplementary Video 2.
Supplementary Video 3.
Supplementary Video 4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Cultrone, D., Zammit, N.W., Self, E. et al. A zebrafish functional genomics model to investigate the role of human A20 variants in vivo. Sci Rep 10, 19085 (2020). https://doi.org/10.1038/s41598-020-75917-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-020-75917-6
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.